Pharmaceutical Product Development Inc

Type: Company
Name: Pharmaceutical Product Development Inc
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Belgium eye care market: Dominated by international brands and manufacturers

(live-PR.com) - The competitive landscape in the Belgium eye care market is concentrated in terms of players, but fragmented in terms of brands. It was almost exclusively in the hands of international brands and manufacturers in 2012. Six companies held ... [Published Live-PR.com - Apr 18 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

Alcon Opens Manufacturing Plant in Singapore to Produce Ophthalmic Pharmaceutical Products

SINGAPORE—On April 14, Alcon officially opened its new $200 million, 330,000-square-foot pharmaceutical manufacturing facility in the Tuas Biomedical Park. Located here to be closer to Alcon’s growing base of customers in Asia, the plant produces ophthalmic ... [Published Vision Monday - Apr 16 2014]
First reported Apr 10 2014 - Updated Apr 10 2014 - 1 reports

AbbVie joins peers in Middle East with Saudi Arabia plans

AbbVie ( $ABBV ) is joining the rush to the Middle East with operations in Saudi Arabia . Its deal for the Arab Company for Pharmaceutical Products (Arabio) to manufacture Humira and other drugs in the kingdom is seen as a significant advance in the country's ... [Published FiercePharma - Apr 10 2014]
First reported Apr 02 2014 - Updated Apr 02 2014 - 1 reports

FDA Approves the Patheon Site in Bourgoin, France to Manufacture Drugs for U.S. Market

Patheon, the pharmaceutical services business owned by DPx Holdings, recently received FDA approval for its Bourgoin, France site to begin manufacturing and selling drugs to the U.S. market. The Bourgoin site specializes in development and commercial ... [Published Individual.com - Apr 02 2014]
First reported Mar 31 2014 - Updated Apr 01 2014 - 1 reports

Investment firm acquires J&J lab testing division

Johnson & Johnson is selling its Ortho-Clinical Diagnostics business to The Carlyle Group for $4 billion, the company announced today.The Washington, D.C.-based global asset management group made a binding offer for the company for $4.15 billion on Jan. ... [Published Shreveport Times - Mar 31 2014]
First reported Mar 30 2014 - Updated Mar 30 2014 - 1 reports

Traditional herbal medicine still saves lives

VietNamNet Bridge – Herbs found in the wild can treat many ailments, so researchers are growing them on a wider scale in order to provide affordable herbal treatments for those in need.Traditional treatment: Charity clinic Tue Tinh Duong Hoa Nam in Hoa ... [Published VietNamNet Bridge - Mar 30 2014]
First reported Mar 27 2014 - Updated Mar 27 2014 - 1 reports

Senior Manager, Quality Assurance Product Disposition

The Senior Manager, Quality Assurance leads and directs quality assurance activities for the Development Organization and assures overall compliance for clinical (and non-clinical research) activities.Serve as QA lead on core ONYX Chemistry Manufacturing ... [Published PharmaDiversity - Mar 27 2014]
First reported Mar 26 2014 - Updated Mar 26 2014 - 1 reports

GLAXOSMITHKLINE : Foreign-Trade Zone 93--Raleigh/Durham, North Carolina, Authorization of Production Activity, GlaxoSmithKline, PLC (Pharmaceutical Products), Zebulon,...

Foreign-Trade Zone 93-- Raleigh/Durham, North Carolina , Authorization of Production Activity, GlaxoSmithKline, PLC (Pharmaceutical Products), Zebulon, North CarolinaCitation: "79 FR 16768"Document Number: "B-98-2013"Page Number : "16768""Notices"On November ... [Published 4 Traders - Mar 26 2014]
First reported Mar 18 2014 - Updated Mar 19 2014 - 2 reports

PPD Selected as Member of New Medical Countermeasure Clinical Studies Network to Address Public Health Emergencies

(Close-Up Media via COMTEX News Network) -- Pharmaceutical Product Development, LLC (PPD) announced that the Biomedical Advanced Research and Development Authority (BARDA) has chosen the company as one of a select group to design and conduct clinical ... [Published PredictWallStreet - Mar 19 2014]
First reported Mar 18 2014 - Updated Mar 18 2014 - 7 reports

PPD, Inc. Enhances Real World Outcomes Capabilities

WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) today announced it has appointed Michael Pollock vice president of real world outcomes. Pollock is responsible for directing and enhancing PPD’s capabilities in health ... [Published BioSpace - Mar 18 2014]
First reported Mar 11 2014 - Updated Mar 12 2014 - 9 reports

DPx Launched as Provider of Pharmaceutical Services, Fine Chemicals, and Proprietary Technologies

DPx Holdings is a new CDMO for the pharmaceutical and related industries, formed from a $2.65 billion transaction between JLL Partners, a private equity firm, and Royal DSM, a life-sciences and materials sciences company. DPx is 51% owned by JLL Partners ... [Published PharmTech.com - Mar 12 2014]
First reported Feb 04 2014 - Updated Feb 04 2014 - 11 reports

PPD Recognized for Training Programs Advancing Clinical Research

WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) was ranked among the top U.S. businesses for employee learning and development by Training magazine. ... [Published EON Business - Feb 04 2014]

Quotes

The theme of this year's PDA Annual Meeting is "Biopharmaceutical and Sterile Pharmaceutical Manufacturing - Embracing Innovation to Meet Global Challenges."
Research and Markets has announced the addition of the "GCC Select Cardiovascular Drugs Market 2012-16 - Analysis of the $7.6 Billion Industry" report to its offerings
...history of excellence in manufacturing sterile injection products," said  Dave Stack , president, chief executive officer and chairman of Pacira. "With EXPAREL on a growth trajectory, we are confident that  Patheon  will ensure our ability to continue supplying EXPAREL to the marketplace beyond the capacity of our current Science Center manufacturing facility in San Diego."

More Content

All (155) | News (103) | Reports (0) | Blogs (44) | Audio/Video (0) | Fact Sheets (3) | Press Releases (5)
sort by: Date | Relevance
Generic’s Counterclaims for Non-Infringement ar... [Published JD Supra - Apr 18 2014]
Belgium eye care market: Dominated by internati... [Published Live-PR.com - Apr 18 2014]
04.17.14 -- Pfizer, Novartis, Merck, And GSK Ex... [Published Pharmaceutical Online - Apr 17 2014]
HIV drug innovator wins 2013 Obasanjo science p... [Published SciDev.Net - Apr 17 2014]
Patheon to Highlight Sterile and Biologic Capab... [Published American Pharmaceutical Outsourcing - Apr 16 2014]
FDA Approves the Patheon site in Bourgoin, Fran... [Published American Pharmaceutical Outsourcing - Apr 16 2014]
Lion : Issuance of Zero Coupon Convertible Bond... [Published 4 Traders - Apr 16 2014]
Alcon Opens Manufacturing Plant in Singapore to... [Published Vision Monday - Apr 16 2014]
Research and Markets Adds Report: GCC Select Ca... [Published Individual.com - Apr 16 2014]
Baxter Addresses Community Needs Through Charit... [Published Asian Hospital & Healthcare Management - Apr 15 2014]
Market Research Reports, Inc. (www.marketresear... [Published BusinessWeek - Apr 15 2014]
Pacira Pharmaceuticals Enters into Strategic Co... [Published Fierce CRO - Apr 14 2014]
Pharmacovigilance Market is Expected to Reach U... [Published PR.com Press Releases - Apr 12 2014]
GCC Select Cardiovascular Drugs Market 2012-16 ... [Published Individual.com - Apr 11 2014]
AbbVie partners with Arabio for production in S... [Published FiercePharmaManufacturing - Apr 10 2014]
AbbVie joins peers in Middle East with Saudi Ar... [Published FiercePharma - Apr 10 2014]
BAXTER : Safety Program Recognized with Local A... [Published 4 Traders - Apr 10 2014]
Baxter : Addresses Community Needs Through Char... [Published 4 Traders - Apr 10 2014]
Safety Program Recognized with Local Awards [Published theCSRfeed - Apr 10 2014]
Patent Issued for Medical Apparatus Employing F... [Published 4 Traders - Apr 10 2014]
Malaysia pharmaceutical market update 2014 [Published pharmaphorum - Apr 09 2014]
AbbVie to produce medicines in KSA [Published Zawya.com - Apr 09 2014]
Eli Lilly & Company (NYSE:LLY) – NY Family Wins... [Published Jutia Group - Apr 08 2014]
KIYATEC appoints Bob Silverman as Board Chairman [Published PRWeb - Apr 04 2014]
Report Published: "Resolute Forest Products, In... [Published SBWire - Apr 02 2014]
FDA Approves the Patheon Site in Bourgoin, Fran... [Published Individual.com - Apr 02 2014]
PPD Selected as Member of New Medical Counterme... [Published Pharmacy Choice - Apr 02 2014]
Patheon to Highlight Sterile and Biologic Capab... [Published MarketWired - Apr 01 2014]
Patheon to Highlight Sterile and Biologic Capab... [Published CisionWire - English - Apr 01 2014]
Global Healthcare BPO Market 2013-2018 - Payer,... [Published Individual.com - Apr 01 2014]
1 2 3 4 5 6
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Pharmacovigilance Market is Expected to Reach U... [Published PR.com Press Releases - Apr 12 2014]
Albany, NY, April 12, 2014 --( PR.com )-- Transparency Market Research "Pharmacovigilance Market Clinical Trial Phases (Pre-Clinical Studies, Phase I, Phase II, Phase III, Phase IV or Post-Marketing Surveillance) and Service Providers (In-House and ...
Safety Program Recognized with Local Awards [Published theCSRfeed - Apr 10 2014]
SOURCE: Baxter International Inc. DESCRIPTION: DEERFIELD, Ill., April 10, 2014 /3BL Media/ – Baxter International Inc. (NYSE: BAX) was recently recognized for safety performance. Baxter China’s Guangzhou manufacturing plant is one of 12 recipients ...
Patheon to Highlight Sterile and Biologic Capab... [Published CisionWire - English - Apr 01 2014]
Patheon (http://www.patheon.com/), the pharmaceutical services business owned by DPx Holdings, will showcase the company’s sterile drug product capabilities and biologic drug substance offerings at the PDA Annual Meeting in San Antonio, Texas, April 7-9, ...
Carlyle Wins $4B Bid for J&J’s Blood Testing Unit [Published Wall St. Cheat Sheet - Mar 31 2014]
Johnson & Johnson ( NYSE:JNJ ) has accepted an $4 billion offer from private equity firm the Carlyle Group for its blood testing unit. According to a Johnson & Johnson press release , “The transaction is expected to close toward the middle of ...
Better Late than Never - JAMA Article Advocates... [Published Health Care Renewal - Mar 20 2014]
Will wonders never cease? Eight years after we started posting about this issue, it has made it into a large circulation medical journal, albeit not completely A JAMA Commentary Decries Leaders of Academic Medical Centers Serving on Boards of Organizations ...
1 2 3 4 5 6 7 8 9

Press Releases

sort by: Date | Relevance
Jazz Pharmaceuticals Announces Acquisition From... [Published PR Newswire - Jan 13 2014]
Royal DSM and JLL create leading pharma service... [Published GlobeNewswire: Acquisitions News - Nov 19 2013]
DSM Celebrates Opening of New cGMP Facility for... [Published PR Newswire - Oct 29 2013]
DSM and Opthea Sign Agreement to Manufacture Op... [Published Financial Services - Oct 29 2013]
New Pharmaceutical Product Launch Spend: Develo... [Published PR Newswire - Sep 20 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.